Impact of prior cancer on eligibility for lung cancer clinical trials
DE Gerber, AL Laccetti, L Xuan… - … the National Cancer …, 2014 - academic.oup.com
… common malignancies, including lung cancer, there are no … the frequency and timing of prior
cancer diagnoses in oncology … prior cancer-related eligibility criteria in lung cancer clinical …
cancer diagnoses in oncology … prior cancer-related eligibility criteria in lung cancer clinical …
Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual
… IV lung cancer patients with prior cancer diagnosis. We quantified the type and stage … prior
cancer in addition to time elapsed between the prior cancer diagnosis and index lung cancer …
cancer in addition to time elapsed between the prior cancer diagnosis and index lung cancer …
Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.
G Giaccone, M Donadio, G Bonardi… - Journal of Clinical …, 1988 - ascopubs.org
… Fifty patients with small-cell lung cancer (SCLC) were treated with … Effectiveness of prior
chemotherapy and time from last … to prior treatment (ie, progressed while on treatment) or re- …
chemotherapy and time from last … to prior treatment (ie, progressed while on treatment) or re- …
[HTML][HTML] Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer
… that they will not tolerate aggressive lung cancer treatment or will have inferior outcomes, …
-modality treatment were simliar between patients with and without a prior cancer diagnosis. …
-modality treatment were simliar between patients with and without a prior cancer diagnosis. …
Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis
… prior cancer may have better lung cancer-specific survival than those without a prior cancer
… but mirrors our findings among patients with metastatic lung cancer [19]. There are few other …
… but mirrors our findings among patients with metastatic lung cancer [19]. There are few other …
Erlotinib in previously treated non–small-cell lung cancer
FA Shepherd, J Rodrigues Pereira… - New England journal …, 2005 - Mass Medical Soc
… In an intention-to-treat analysis of all patients randomly assigned to treatment, the disease-…
-cell lung cancer was not significantly altered by performance status, prior treatments, prior …
-cell lung cancer was not significantly altered by performance status, prior treatments, prior …
Volumetric growth rate of stage I lung cancer prior to treatment: serial CT scanning
HT Winer-Muram, SG Jennings, RD Tarver, AM Aisen… - Radiology, 2002 - pubs.rsna.org
… volumes of lung cancers prior to treatment. The … prior to treatment ( , Figure). The purpose
of this study was to determine the range of growth rates of stage I lung cancers prior to treatment…
of this study was to determine the range of growth rates of stage I lung cancers prior to treatment…
Targeted therapies for treatment of non‐small cell lung cancer—recent advances and future perspectives
J Minguet, KH Smith, P Bramlage - … journal of cancer, 2016 - Wiley Online Library
… form of cancer. Over the last decades, lung cancer has been the leading cause of cancer-…
efficacy and safety of ceritinib in patients with and without prior treatment are ongoing.92 …
efficacy and safety of ceritinib in patients with and without prior treatment are ongoing.92 …
[HTML][HTML] Predicting lung cancer prior to surgical resection in patients with lung nodules
… model to help diagnose a suspected lung cancer without missing early stage disease; …
Treatment (TREAT) lung cancer prediction model and compared the performance of the TREAT …
Treatment (TREAT) lung cancer prediction model and compared the performance of the TREAT …
Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non–small cell lung cancer after failure of at least one prior chemotherapy …
JR Johnson, M Cohen, R Sridhara, YF Chen… - Clinical Cancer …, 2005 - AACR
… , on erlotinib treatment effect. Lung cancer is the leading cause of cancer death in both men
… Initial therapy for advanced non–small lung cancer (NSCLC) is systemic chemotherapy with …
… Initial therapy for advanced non–small lung cancer (NSCLC) is systemic chemotherapy with …
相关搜索
- patients with previously treated lung cancer
- cell lung cancer
- lung cancer targeted therapy
- lung cancer clinical trials
- non-small cell lung cancer patients
- small cell lung cancer prior chemotherapy
- younger patients with lung cancer
- lung cancer in england
- outcomes in advanced lung cancer
- erlotinib in lung cancer
- lung cancer in symptomatic patients
- lung cancer in populations
- lung cancer risk in patients
- chemotherapy for advanced lung cancer
- older patients with lung cancer
- characteristics of lung cancer